company background image
ACT logo

AlzChem Group Informe acción XTRA:ACT

Último precio

€44.00

Capitalización de mercado

€447.8m

7D

-3.9%

1Y

130.4%

Actualizada

03 May, 2024

Datos

Finanzas de la empresa +

AlzChem Group AG

Informe acción XTRA:ACT

Capitalización de mercado: €447.8m

Resumen de acción ACT

AlzChem Group AG, junto con sus filiales, desarrolla, produce y comercializa productos químicos en Alemania, la Unión Europea, el resto de Europa, Asia, la región NAFTA y a escala internacional.

ACT fundamental analysis
Snowflake Score
Valuation5/6
Future Growth2/6
Past Performance6/6
Financial Health6/6
Dividends3/6

Competidores de AlzChem Group AG

Historial de precios y rendimiento

Summary of all time highs, changes and price drops for AlzChem Group
Historical stock prices
Current Share Price€44.00
52 Week High€48.00
52 Week Low€17.55
Beta1.1
1 Month Change13.70%
3 Month Change88.03%
1 Year Change130.37%
3 Year Change72.55%
5 Year Change98.20%
Change since IPO63.63%

Noticias y actualizaciones recientes

Recent updates

Shareholders Will Probably Hold Off On Increasing AlzChem Group AG's (ETR:ACT) CEO Compensation For The Time Being

May 01
Shareholders Will Probably Hold Off On Increasing AlzChem Group AG's (ETR:ACT) CEO Compensation For The Time Being

AlzChem Group's (ETR:ACT) Upcoming Dividend Will Be Larger Than Last Year's

Apr 26
AlzChem Group's (ETR:ACT) Upcoming Dividend Will Be Larger Than Last Year's

Is AlzChem Group (ETR:ACT) A Risky Investment?

Apr 11
Is AlzChem Group (ETR:ACT) A Risky Investment?

AlzChem Group's (ETR:ACT) Dividend Will Be Increased To €1.20

Mar 29
AlzChem Group's (ETR:ACT) Dividend Will Be Increased To €1.20

The Market Lifts AlzChem Group AG (ETR:ACT) Shares 26% But It Can Do More

Mar 07
The Market Lifts AlzChem Group AG (ETR:ACT) Shares 26% But It Can Do More

Why AlzChem Group AG (ETR:ACT) Could Be Worth Watching

Nov 01
Why AlzChem Group AG (ETR:ACT) Could Be Worth Watching

Is There An Opportunity With AlzChem Group AG's (ETR:ACT) 42% Undervaluation?

Oct 12
Is There An Opportunity With AlzChem Group AG's (ETR:ACT) 42% Undervaluation?

AlzChem Group (ETR:ACT) Is Increasing Its Dividend To €1.05

May 06
AlzChem Group (ETR:ACT) Is Increasing Its Dividend To €1.05

AlzChem Group AG's (ETR:ACT) CEO Compensation Is Looking A Bit Stretched At The Moment

May 05
AlzChem Group AG's (ETR:ACT) CEO Compensation Is Looking A Bit Stretched At The Moment

AlzChem Group (ETR:ACT) Will Pay A Larger Dividend Than Last Year At €1.05

Apr 05
AlzChem Group (ETR:ACT) Will Pay A Larger Dividend Than Last Year At €1.05

AlzChem Group (ETR:ACT) Is Increasing Its Dividend To €1.05

Mar 04
AlzChem Group (ETR:ACT) Is Increasing Its Dividend To €1.05

AlzChem Group (ETR:ACT) Is Paying Out A Larger Dividend Than Last Year

Apr 24
AlzChem Group (ETR:ACT) Is Paying Out A Larger Dividend Than Last Year

AlzChem Group's (ETR:ACT) Dividend Will Be Increased To €1.00

Mar 29
AlzChem Group's (ETR:ACT) Dividend Will Be Increased To €1.00

AlzChem Group (ETR:ACT) Has Announced That It Will Be Increasing Its Dividend To €1.00

Feb 27
AlzChem Group (ETR:ACT) Has Announced That It Will Be Increasing Its Dividend To €1.00

AlzChem Group (ETR:ACT) Posted Healthy Earnings But There Are Some Other Factors To Be Aware Of

Nov 23
AlzChem Group (ETR:ACT) Posted Healthy Earnings But There Are Some Other Factors To Be Aware Of

Are Investors Undervaluing AlzChem Group AG (ETR:ACT) By 46%?

Jun 10
Are Investors Undervaluing AlzChem Group AG (ETR:ACT) By 46%?

At €24.50, Is AlzChem Group AG (ETR:ACT) Worth Looking At Closely?

Apr 07
At €24.50, Is AlzChem Group AG (ETR:ACT) Worth Looking At Closely?

AlzChem Group AG (ETR:ACT) Is Yielding 3.0% - But Is It A Buy?

Mar 23
AlzChem Group AG (ETR:ACT) Is Yielding 3.0% - But Is It A Buy?

AlzChem Group AG's (ETR:ACT) Intrinsic Value Is Potentially 32% Above Its Share Price

Mar 10
AlzChem Group AG's (ETR:ACT) Intrinsic Value Is Potentially 32% Above Its Share Price

Is AlzChem Group AG's (ETR:ACT) Recent Stock Performance Influenced By Its Fundamentals In Any Way?

Feb 24
Is AlzChem Group AG's (ETR:ACT) Recent Stock Performance Influenced By Its Fundamentals In Any Way?

Our Take On The Returns On Capital At AlzChem Group (ETR:ACT)

Feb 11
Our Take On The Returns On Capital At AlzChem Group (ETR:ACT)

Update: AlzChem Group (ETR:ACT) Stock Gained 13% In The Last Year

Aug 07
Update: AlzChem Group (ETR:ACT) Stock Gained 13% In The Last Year

Is Now An Opportune Moment To Examine AlzChem Group AG (ETR:ACT)?

Jul 20
Is Now An Opportune Moment To Examine AlzChem Group AG (ETR:ACT)?

Does This Valuation Of AlzChem Group AG (ETR:ACT) Imply Investors Are Overpaying?

Jul 03
Does This Valuation Of AlzChem Group AG (ETR:ACT) Imply Investors Are Overpaying?

Rentabilidad de los accionistas

ACTDE ChemicalsMercado DE
7D-3.9%-1.9%-0.5%
1Y130.4%1.5%2.5%

Rentabilidad vs. Industria: ACT superó al sector German Chemicals , que obtuvo un rendimiento del -1.3% el año pasado.

Rentabilidad vs. Mercado: ACT superó al mercado German, que obtuvo un rendimiento del 2.3% el año pasado.

Volatilidad de los precios

Is ACT's price volatile compared to industry and market?
ACT volatility
ACT Average Weekly Movement5.5%
Chemicals Industry Average Movement3.5%
Market Average Movement4.9%
10% most volatile stocks in DE Market10.3%
10% least volatile stocks in DE Market2.4%

Precio estable de las acciones: El precio de las acciones de ACT ha sido volátil en los últimos 3 meses.

Volatilidad a lo largo del tiempo: La volatilidad semanal de ACT (5%) se ha mantenido estable durante el año pasado.

Acerca de la empresa

FundadaEmpleadosCEOPágina web
19081,607Andreas Niedermaierwww.alzchem.com

AlzChem Group AG, junto con sus filiales, desarrolla, produce y comercializa productos químicos en Alemania, la Unión Europea, el resto de Europa, Asia, la región NAFTA e internacionalmente. Opera a través de tres segmentos: Productos químicos especiales, Productos básicos e intermedios, y Otros y Holding. La empresa ofrece suplementos dietéticos con las marcas Creapure y Alipure; preparación de ácido guanidinoacético como aditivo nutricional para piensos con la marca Creamino; suplementos dietéticos de creatina con la marca LIVADUR; productos para productos farmacéuticos con la marca Bioselect; agentes de curado, incluidos aceleradores para uso en adhesivos, revestimientos en polvo, placas de circuitos impresos y materiales compuestos con la marca DYHARD; y nitruro de silicio para cerámica y aplicaciones electrónicas y solares con la marca SILZOT.

Resumen de fundamentos de AlzChem Group AG

¿Cómo se comparan los beneficios e ingresos de AlzChem Group con su capitalización de mercado?
Estadísticas fundamentales de ACT
Capitalización bursátil€447.76m
Beneficios(TTM)€39.15m
Ingresos (TTM)€543.40m

11.4x

Ratio precio-beneficio (PE)

0.8x

Ratio precio-ventas (PS)

Beneficios e Ingresos

Estadísticas clave de rentabilidad del último informe de resultados (TTM)
Cuenta de resultados (TTM) de ACT
Ingresos€543.40m
Coste de los ingresos€226.23m
Beneficio bruto€317.17m
Otros gastos€278.02m
Beneficios€39.15m

Últimos beneficios comunicados

Mar 31, 2024

Próxima fecha de beneficios

n/a

Beneficios por acción (BPA)3.85
Margen bruto58.37%
Margen de beneficio neto7.20%
Ratio deuda/patrimonio0%

¿Cómo se ha desempeñado ACT a largo plazo?

Ver rendimiento histórico y comparativa

Dividendos

2.7%

Rentabilidad actual por dividendo

31%

Ratio de pagos
¿Cuándo hay que comprar ACT para recibir un próximo dividendo?
fechas de dividendos de AlzChem Group
Fecha ex dividendoMay 08 2024
Fecha de pago de dividendosMay 10 2024
Días hasta ex dividendo4 days
Días hasta la fecha de pago de dividendos6 days